Citadel Advisors
YCBD icon

Citadel Advisors’s cbdMD YCBD Stock Holding History

Citadel Advisors’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-61
Closed -$4.99K – 15626
2022
Q4 		$4.99K Sell
61
-2
-3% -$201 ﹤0.01% 14043
2022
Q3 		$5K Sell
63
-20
-24% -$2.87K ﹤0.01% 12376
2022
Q2 		$13K Buy
83
+9
+12% +$2.13K ﹤0.01% 12527
2022
Q1 		$28K Sell
74
-63
-46% -$21.3K ﹤0.01% 13134
2021
Q4 		$53K Buy
137
+49
+56% +$28.5K ﹤0.01% 13219
2021
Q3 		$66K Sell
88
-63
-42% -$52.7K ﹤0.01% 13203
2021
Q2 		$158K Buy
151
+24
+19% +$28.7K ﹤0.01% 12443
2021
Q1 		$189K Buy
127
+48
+61% +$69.8K ﹤0.01% 11774
2020
Q4 		$84K Sell
79
-376
-83% -$342K ﹤0.01% 10324
2020
Q3 		$328K Buy
455
+106
+30% +$101K ﹤0.01% 7984
2020
Q2 		$240K Buy
+349
New +$157K ﹤0.01% 8268

Other funds holding YCBD

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's YCBD Position: Q3 2025 in Review

Citadel Advisors sold out of cbdMD (YCBD) in Q3 2025, closing a stake of 59,142 shares — an estimated $52.7K sold.

Citadel Advisors first reported a position in YCBD in Q2 2018 and held it in 12 quarters. The position peaked at $157K in Q1 2021. 20 funds tracked by Wall St. Rank hold YCBD as of Q3 2025.

  • Citadel Advisors reported no remaining cbdMD position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 59,142 cbdMD shares in Q3 2025, an estimated $52.7K.
  • Citadel Advisors first reported a position in cbdMD in Q2 2018 and held it in 12 quarters.
  • Citadel Advisors's cbdMD position peaked at $157K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.